The multidisciplinary Innovative Research Grants Committee was appointed by the Scientific Advisory Committee to conduct a rigorous, multi-step evaluation of the innovative grant proposals. The 45-member committee is led by Richard D. Kolodner, Ph.D., along with Vice-Chairpersons William G. Kaelin Jr., M.D., and William G. Nelson V, M.D., Ph.D.
The expert members of the Innovative Research Grants Committee are:
Richard D. Kolodner, Ph.D., Chairperson
Professor of Medicine
University of California, San Diego
Ludwig Institute for Cancer Research
La Jolla, CA
William G. Kaelin Jr., M.D., Vice-Chairperson
Professor
Dana-Farber Cancer Institute
Boston, MA
William G. Nelson V, M.D., Ph.D., Vice Chairperson
Director
Sidney Kimmel Comprehensive Cancer Center
Baltimore, MD
James P. Allison, Ph.D.
Chairman, Immunology Program
Memorial Sloan-Kettering Cancer Center
New York, NY
Christine B. Ambrosone, Ph.D.
Chair, Department of Cancer Prevention and Control
Roswell Park Cancer Institute
Buffalo, NY
Frederick R. Appelbaum, M.D.
Director, Clinical Research Division
Fred Hutchinson Cancer Research Center
Seattle, WA
Myles A. Brown, M.D.
Professor of Medicine
Dana-Farber Cancer Institute
Boston, MA
Lisa M. Coussens, Ph.D.
Professor, Department of Pathology
University of California, San Francisco, Comprehensive Cancer Center
San Francisco, CA
Nancy E. Davidson, M.D.
Director
University of Pittsburgh Cancer Institute
Pittsburgh, PA
Steven M. Dubinett, M.D.
Professor of Medicine and Pathology
Director, University of California Los Angeles Lung Cancer Research Program
UCLA David Geffen School of Medicine
Los Angeles, CA
Wafik S. El-Deiry, M.D., Ph.D.
Professor of Medicine, Genetics, and Pharmacology
University of Pennsylvania School of Medicine
Philadelphia, PA
David M. Epstein, Ph.D.
Senior Vice President, Oncology
OSI Pharmaceuticals, Inc.
Farmingdale, NY
Judy E. Garber, M.D.
Associate Professor, Medical Oncology
Dana-Farber Cancer Institute
Boston, MA
Lawrence S.B. Goldstein, Ph.D.
Professor, Cellular and Molecular Medicine
University of California, San Diego
La Jolla, CA
F. Peter Guengerich, Ph.D.
Professor, Department of Biochemistry
Vanderbilt University School of Medicine
Nashville, TN
William C. Hahn, M.D., Ph.D.
Associate Professor, Department of Medical Oncology
Dana-Farber Cancer Institute
Boston, MA
Ernest T. Hawk, M.D.
Vice President and Division Head, Division of Cancer Prevention and Population
UT M. D. Anderson Cancer Center
Houston, TX
Lee J. Helman, M.D.
Scientific Director for Clinical Research
National Cancer Institute
Bethesda, MD
Mary J.C. Hendrix, Ph.D.
President and Scientific Director
Children's Memorial Research Center
Chicago, IL
David E. Hill, Ph.D.
Principal Research Scientist and Associate Director
Dana-Farber Cancer Institute
Boston, MA
Selwyn Hurwitz, Ph.D.
Assistant Professor
Emory University School of Medicine
Decatur, GA
Catriona H.M. Jamieson, M.D., Ph.D.
Assistant Professor, Division of Hematology/Oncology
University of California San Diego Moores Cancer Center
La Jolla, CA
Erik S. Knudsen, Ph.D.
Deputy Director for Research, Kimmel Cancer Center
Professor of Cancer Biology, Thomas Jefferson University
Philadelphia, PA
Raju Kucherlapati, Ph.D.
Paul C. Cabor Professor of Genetics, Professor of Medicine
Harvard Medical School
Boston, MA
John S. Lazo, Ph.D.
Institute Director and Professor, Pharmacology Department
University of Pittsburgh School of Medicine
Pittsburgh, PA
Douglas R. Lowy, M.D.
Chief, Laboratory of Cellular Oncology
National Cancer Institute Center for Cancer Research
Bethesda, MD
Lawrence J. Marnett, Ph.D.
Professor of Biochemistry
Vanderbilt University Medical Center
Nashville, TN
Howard L. McLeod, Pharm.D.
Director, UNC Institute for Pharmacogenomics and Individualized Therapy
University of North Carolina
Chapel Hill, NC
Gordon B. Mills, M.D., Ph.D.
Chairman, Department of Systems Biology
UT M. D. Anderson Cancer Center
Houston, TX
John D. Minna, M.D.
Director, Hamon Center for Therapeutic Oncology Research
UT Southwestern Medical Center
Dallas, TX
Richard J. O'Reilly, M.D.
Chairman, Department of Pediatrics
Memorial Sloan-Kettering Cancer Center
New York, NY
Ellen Puré, Ph.D.
Professor and Associate Vice President of Academic Affairs
The Wistar Institute
Philadelphia, PA
Gregory H. Reaman, M.D.
Chairman, Children's Oncology Group
Professor of Pediatrics, The George Washington University School of Medicine and Health Sciences
Washington, DC
Saul Rosenberg, Ph.D.
Senior Director, Cancer Research
Abbott Laboratories
Abbott Park, IL
Eric H. Rubin, M.D.
Vice President, Oncology Clinical Research
Merck Research Laboratories
North Wales, PA
Gary Ruvkun, Ph.D.
Professor
Department of Genetics, Harvard Medical School
Department of Molecular Biology, Massachusetts General Hospital
Boston, MA
Michael B. Sporn, M.D.
Professor of Pharmacology and Medicine
Dartmouth Medical School
Hanover, NH
Charles D. Stiles, Ph.D.
Professor
Dana-Farber Cancer Institute
Boston, MA
Annick D. Van den Abbeele, M.D.
Chief, Department of Imaging
Founding Director, Center for Biomedical Imaging in Oncology
Dana-Farber Cancer Institute
Boston, MA
Gregory L. Verdine, Ph.D.
Erving Professor, Department of Chemistry and Chemical Biology
Harvard University
Cambridge, MA
Inder Verma, Ph.D.
ACS Professor of Medical Biology, Laboratory of Genetics
Salk Institute Cancer Center
La Jolla, CA
Geoffrey M. Wahl, Ph.D.
Professor, Gene Expression Laboratory
Salk Institute Cancer Center
La Jolla, CA
Louis M Weiner, M.D.
Director, Lombardi Comprehensive Cancer Center
Francis L. and Charlotte G. Gragnani Chair and Professor, Department of Oncology
Georgetown University Medical Center
Washington, DC
Cheryl L. Willman, M.D.
Director and Chief Executive Officer
University of New Mexico Cancer Center
Albuquerque, NM
Owen N. Witte, M.D.
Professor of Microbiology, Immunology and Molecular Genetics
University of California, Los Angeles
Los Angeles, CA